Status of our health-related genetic reports.

In February, 2015, 23andMe was granted authorization
by the U.S. Food and Drug Administration (FDA) to
market the Bloom syndrome carrier status report.
This is an important first step in fulfilling our
commitment to return genetic health reports to
consumers.

This is the first-time the FDA has granted
authorization to market a direct-to-consumer genetic
test, and it gives us a regulatory framework for
future submissions.

While this authorization is for a single carrier
status test only; we are committed to returning
health information to our US customers who don’t
already have this information once more tests have
been through this process and we have a more
comprehensive product offering.

At this time, we do not know which health reports
might be available or when they might be available.

How does this impact you?

Current Customers

Current 23andMe customers who received health-related results prior to November 22, 2013 will continue
to have access to that information. However, no new health-related updates will be provided to your account.

Customers who purchased kits before November 22, 2013 will still receive health-related results.

Customers who purchase or have purchased 23andMe’s Personal Genome Service (PGS) on or after
November 22, 2013, (date of compliance letter issued by the FDA) will receive their ancestry information
and uninterpreted raw genetic data. At this time, we do not know the timeline as to which health reports
might be available in the future or when they might be available.

Customers who purchased kits on or after November 22, 2013 through December 5, 2013 are eligible for a refund.
23andMe has notified all eligible customers by email with refund instructions. If you are eligible and have
not received an email, please click
here.

New Customers

If you purchase today, you are purchasing ancestry-related information and uninterpreted raw genetic
data for $99.

At this time, we do not know the timeline as to which health reports might be available in the future
or when they might be available.

Your raw genetic data will be available for you to download.

We want to make clear that we stand behind the data we generate for customers and are proud of profoundly improving
the lives of so many customers. Our lab partner adheres to strict quality standards that are part of the Clinical
Laboratory Improvement Amendments of 1988 — known as CLIA. These are the same standards used in the majority of
other health and disease-related tests. We decided several years ago to comply with CLIA guidelines to be consistent
with other types of laboratory testing and to assure customers about the quality of data.

We remain firmly committed to fulfilling our long-term
mission to help people access, understand and benefit from
the human genome.

Our EU product is in English only, and due to applicable regulations it is only available for customers with a shipping address in Denmark, Finland, Ireland, Sweden and the Netherlands. If you are shipping to one of these countries continue to the: EU site →

If you are shipping to England, Scotland or Wales visit the: UK site →

For other countries, the US product is available and can be shipped internationally from the: US site →

Our EU product is in English only, and due to applicable regulations it is only available for customers with a shipping address in Denmark, Finland, Ireland, Sweden and the Netherlands. If you are shipping to one of these countries continue to the: EU site →